Stanley Frankel
CIK: 0001855726
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRECISION BIOSCIENCES INC
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 3, 2026DTIL
PRECISION BIOSCIENCES INC
Award(A)DirectRestricted Stock Units
21K shares- - May 20, 2026DTIL
PRECISION BIOSCIENCES INC
Exercise(M)Direct21K shares- - Dec 16, 2025DTIL
PRECISION BIOSCIENCES INC
Purchase(P)Direct2.7K shares at avg. $4.70$13K - Sep 26, 2025DTIL
PRECISION BIOSCIENCES INC
Purchase(P)Direct2.7K shares at avg. $4.97$13K - Jun 3, 2025DTIL
PRECISION BIOSCIENCES INC
Award(A)DirectRestricted Stock Units
21K shares- - May 27, 2025DTIL
PRECISION BIOSCIENCES INC
Exercise(M)Direct9.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | DTIL PRECISION BIOSCIENCES INC | Award(A) Restricted Stock Units | 20,979 | - | - | Direct |
| May 20, 2026 | DTIL PRECISION BIOSCIENCES INC | Exercise(M) | 21,000 | - | $0 | Direct |
| Dec 16, 2025 | DTIL PRECISION BIOSCIENCES INC | Purchase(P) | 2,700 | $4.70 | $12,690 | Direct |
| Sep 26, 2025 | DTIL PRECISION BIOSCIENCES INC | Purchase(P) | 2,700 | $4.97 | $13,419 | Direct |
| Jun 3, 2025 | DTIL PRECISION BIOSCIENCES INC | Award(A) Restricted Stock Units | 21,000 | - | - | Direct |
| May 27, 2025 | DTIL PRECISION BIOSCIENCES INC | Exercise(M) | 9,826 | - | - | Direct |
1-6 of 6 transactions
About Frankel Stanley
Frankel Stanley (SEC CIK 0001855726) files insider reports with the SEC as Director of PRECISION BIOSCIENCES INC (DTIL).
Signal8 holds 5 ownership filings by Frankel Stanley, all Form 4s, filed between Jun 4, 2025 and Jun 5, 2026. Those filings report 6 transactions, from May 27, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Frankel Stanley's filings is in DURHAM, NC.
Recent filings by Frankel Stanley
- Jun 3, 2026: Grant or award of DTIL derivative securities (Form 4, code A).
- May 20, 2026: Option exercise of DTIL shares (Form 4, code M).
- Dec 16, 2025: Open-market purchase of DTIL shares (Form 4, code P).
- Sep 26, 2025: Open-market purchase of DTIL shares (Form 4, code P).
- Jun 3, 2025: Grant or award of DTIL derivative securities (Form 4, code A).
Other insiders filing for PRECISION BIOSCIENCES INC (DTIL)
- Brown Melinda, Director
- Germano Geno J, Director
- Gorsuch Cassandra Louise, Chief Scientific Officer
- Burris Mei Zhang Lu, Chielf Accounting Officer
- Tanna Naresh Haresh, Chief Financial Officer
- Pire Shari Lisa, Director